Gene expression markers of efficacy and resistance to cetuximab treatment in metastatic colorectal cancer: results from CALGB 80203 (Alliance)
Cushman, Stephanie M, Jiang, Chen, Hatch, Ace J, Shterev, Ivo, Sibley, Alexander B, Niedzwiecki, Donna, Venook, Alan P, Owzar, Kouros, Hurwitz, Herbert I, Nixon, Andrew B
Published in Clinical cancer research (01.03.2015)
Published in Clinical cancer research (01.03.2015)
Get full text
Journal Article
Genetic variation determines VEGF-A plasma levels in cancer patients
Innocenti, Federico, Jiang, Chen, Sibley, Alexander B, Etheridge, Amy S, Hatch, Ace J, Denning, Stefanie, Niedzwiecki, Donna, Shterev, Ivo D, Lin, Jiaxing, Furukawa, Yoichi, Kubo, Michiaki, Kindler, Hedy L, Auman, J Todd, Venook, Alan P, Hurwitz, Herbert I, McLeod, Howard L, Ratain, Mark J, Gordan, Raluca, Nixon, Andrew B, Owzar, Kouros
Published in Scientific reports (05.11.2018)
Published in Scientific reports (05.11.2018)
Get full text
Journal Article
Dynamic Changes in Circulating Tumor DNA During Chemoradiation for Locally Advanced Lung Cancer
Corradetti, Michael N., MD, PhD, Torok, Jordan A., MD, Hatch, Ace J., PhD, Xanthopoulos, Eric P., MD, JD, Lafata, Kyle, PhD, Jacobs, Corbin, MD, Rushing, Christel, MA, Calaway, John, PhD, Jones, Greg, MS, Kelsey, Chris R., MD, Nixon, Andrew B., PhD
Published in Advances in radiation oncology (01.10.2019)
Published in Advances in radiation oncology (01.10.2019)
Get full text
Journal Article
Blood‐based markers of efficacy and resistance to cetuximab treatment in metastatic colorectal cancer: results from CALGB 80203 (Alliance)
Hatch, Ace J., Sibley, Alexander B., Starr, Mark D., Brady, J. Chris, Jiang, Chen, Jia, Jingquan, Bowers, Daniel L., Pang, Herbert, Owzar, Kouros, Niedzwiecki, Donna, Innocenti, Federico, Venook, Alan P., Hurwitz, Herbert I., Nixon, Andrew B.
Published in Cancer medicine (Malden, MA) (01.09.2016)
Published in Cancer medicine (Malden, MA) (01.09.2016)
Get full text
Journal Article
Plasma Protein Biomarkers in Advanced or Metastatic Colorectal Cancer Patients Receiving Chemotherapy With Bevacizumab or Cetuximab: Results from CALGB 80405 (Alliance)
Nixon, Andrew B, Sibley, Alexander B, Liu, Yingmiao, Hatch, Ace J, Jiang, Chen, Mulkey, Flora, Starr, Mark D, Brady, John C, Niedzwiecki, Donna, Venook, Alan P, Baez-Diaz, Luis, Lenz, Heinz-Josef, O'Neil, Bert H, Innocenti, Federico, Meyerhardt, Jeffrey A, O'Reilly, Eileen M, Owzar, Kouros, Hurwitz, Herbert I
Published in Clinical cancer research (01.07.2022)
Published in Clinical cancer research (01.07.2022)
Get full text
Journal Article
Prognostic and Predictive Biomarkers in Patients with Metastatic Colorectal Cancer Receiving Regorafenib
Liu, Yingmiao, Lyu, Jing, Bell Burdett, Kirsten, Sibley, Alexander B., Hatch, Ace J., Starr, Mark D., Brady, John C., Hammond, Kelli, Marmorino, Federica, Rossini, Daniele, Goldberg, Richard M., Falcone, Alfredo, Cremolini, Chiara, Owzar, Kouros, Ivanova, Anastasia, Moore, Dominic T., Lee, Michael S., Sanoff, Hanna K., Innocenti, Federico, Nixon, Andrew B.
Published in Molecular cancer therapeutics (01.10.2020)
Published in Molecular cancer therapeutics (01.10.2020)
Get full text
Journal Article
Inositol phosphate multikinase dependent transcriptional control
Hatch, Ace J., Odom, Audrey R., York, John D.
Published in Advances in biological regulation (01.05.2017)
Published in Advances in biological regulation (01.05.2017)
Get full text
Journal Article
Cabozantinib and Panitumumab for RAS Wild‐Type Metastatic Colorectal Cancer
Strickler, John H., Rushing, Christel N., Uronis, Hope E., Morse, Michael A., Niedzwiecki, Donna, Blobe, Gerard C., Moyer, Ashley N., Bolch, Emily, Webb, Renee, Haley, Sherri, Hatch, Ace J., Altomare, Ivy P., Sherrill, Gary B., Chang, David Z., Wells, James L., Hsu, S. David, Jia, Jingquan, Zafar, S. Yousuf, Nixon, Andrew B., Hurwitz, Herbert I.
Published in The oncologist (Dayton, Ohio) (01.06.2021)
Published in The oncologist (Dayton, Ohio) (01.06.2021)
Get full text
Journal Article
A Phase I Trial of the IGF‐1R Antibody Ganitumab (AMG 479) in Combination with Everolimus (RAD001) and Panitumumab in Patients with Advanced Cancer
Vlahovic, Gordana, Meadows, Kellen L., Hatch, Ace J., Jia, Jingquan, Nixon, Andrew B., Uronis, Hope E., Morse, Michael A., Selim, M. Angelica, Crawford, Jeffrey, Riedel, Richard F., Zafar, S. Yousuf, Howard, Leigh A., O'Neill, Margot, Meadows, Jennifer J., Haley, Sherri T., Arrowood, Christy C., Rushing, Christel, Pang, Herbert, Hurwitz, Herbert I.
Published in The oncologist (Dayton, Ohio) (01.07.2018)
Published in The oncologist (Dayton, Ohio) (01.07.2018)
Get full text
Journal Article
An initial genetic analysis of gemcitabine-induced high-grade neutropenia in pancreatic cancer patients in CALGB 80303 (Alliance)
Innocenti, Federico, Jiang, Chen, Sibley, Alexander B, Denning, Stefanie, Etheridge, Amy S, Watson, Dorothy, Niedzwiecki, Donna, Hatch, Ace J, Hurwitz, Herbert I, Nixon, Andrew B, Furukawa, Yoichi, Kubo, Michiaki, Crona, Daniel J, Kindler, Hedy L, McLeod, Howard L, Ratain, Mark J, Owzar, Kouros
Published in Pharmacogenetics and genomics (01.08.2019)
Published in Pharmacogenetics and genomics (01.08.2019)
Get more information
Journal Article
RasGRP1 is a potential biomarker for stratifying anti-EGFR therapy response in colorectal cancer
Gbenedio, Oghenekevwe M., Bonnans, Caroline, Grun, Delphine, Wang, Chih-Yang, Hatch, Ace J., Mahoney, Michelle R., Barras, David, Matli, Mary, Miao, Yi, Garcia, K. Christopher, Tejpar, Sabine, Delorenzi, Mauro, Venook, Alan P., Nixon, Andrew B., Warren, Robert S., Roose, Jeroen P., Depeille, Philippe
Published in JCI insight (08.08.2019)
Published in JCI insight (08.08.2019)
Get full text
Journal Article
Prognostic and predictive blood-based biomarkers of overall survival (OS) in patients (pts) with advanced colorectal cancer (CRC) treated with cetuximab (C): Results from CALGB 80203 (Alliance)
Hatch, Ace J., Pang, Herbert, Starr, Mark D., Brady, John C., Jia, Jingquan, Niedzwiecki, Donna, Venook, Alan Paul, Cushman, Stephanie M., Hurwitz, Herbert, Nixon, Andrew B.
Published in Journal of clinical oncology (20.01.2014)
Published in Journal of clinical oncology (20.01.2014)
Get full text
Journal Article
RasGRP1 is a potential biomarker for stratifying anti-EGFR therapy response in colorectal cancer
Gbenedio, Oghenekevwe M, Bonnans, Caroline, Grun, Delphine, Wang, Chih-Yang, Hatch, Ace J, Mahoney, Michelle R, Barras, David, Matli, Mary, Miao, Yi, Christopher, K, Tejpar, Sabine, Delorenzi, Mauro, Venook, Alan P, Nixon, Andrew B, Warren, Robert S, Roose, Jeroen P, Depeille, Philippe
Published in JCI insight (08.08.2019)
Published in JCI insight (08.08.2019)
Get full text
Journal Article
RasGRP1 is a potential biomarker for stratifying anti-EGFR therapy response in colorectal cancer
Gbenedio, Oghenekevwe M, Bonnans, Caroline, Grun, Delphine, Wang, Chih-Yang, Hatch, Ace J, Mahoney, Michelle R, Barras, David, Matli, Mary, Miao, Yi, Christopher, K, Tejpar, Sabine, Delorenzi, Mauro, Venook, Alan P, Nixon, Andrew B, Warren, Robert S, Roose, Jeroen P, Depeille, P.
Published in JCI insight (08.08.2019)
Published in JCI insight (08.08.2019)
Get full text
Journal Article
RasGRP1 is a potential biomarker to stratify anti-EGFR therapy response in colorectal cancer
Gbenedio, Oghenekevwe M, Bonnans, Caroline, Grun, Delphine, Wang, Chih-Yang, Hatch, Ace J, Mahoney, Michelle R, Barras, David, Matli, Mary, Miao, Yi, Garcia, K Christopher, Tejpar, Sabine, Delorenzi, Mauro, Venook, Alan P, Nixon, Andrew B, Warren, Robert S, Roose, Jeroen P, Depeille, Philippe
Published in JCI insight (25.06.2019)
Published in JCI insight (25.06.2019)
Get full text
Journal Article
METHODS OF PREDICTING RESPONSIVENESS OF A CANCER TO AN AGENT AND METHODS OF DETERMINING A PROGNOSIS FOR A CANCER PATIENT
JIANG CHEN, SHTEREV IVO, NIXON ANDREW B, HURWITZ HERBERT I, SIBLEY ALEXANDER B, CUSHMAN STEPHANIE MACKEY, OWZAR KOUROS, HATCH ACE J
Year of Publication 28.01.2016
Get full text
Year of Publication 28.01.2016
Patent